Results 151 to 160 of about 6,819,213 (411)

Evolution of the eukaryotic protein kinases as dynamic molecular switches

open access: yesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2012
Protein kinases have evolved in eukaryotes to be highly dynamic molecular switches that regulate a plethora of biological processes. Two motifs, a dynamic activation segment and a GHI helical subdomain, distinguish the eukaryotic protein kinases (EPKs ...
Susan S. Taylor   +3 more
semanticscholar   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

open access: yesMolecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster   +3 more
wiley   +1 more source

The Binary Classification of Protein Kinases

open access: yesJournal of Inflammation Research, 2021
Zeev Elkoshi Research and Development Department, Taro Pharmaceutical Industries Ltd, Haifa, IsraelCorrespondence: Zeev Elkoshi Email zeev.elkoshi@gmail.comAbstract: In an earlier publication a binary model for chronic diseases classification has been ...
Elkoshi Z
doaj  

SnRK2 protein kinases represent an ancient system in plants for adaptation to a terrestrial environment [PDF]

open access: gold, 2019
Akihisa Shinozawa   +17 more
openalex   +1 more source

Cyclin-dependent kinases

open access: yesGenome Biology, 2014
Cyclin-dependent kinases (CDKs) are protein kinases characterized by needing a separate subunit - a cyclin - that provides domains essential for enzymatic activity.
Marcos Malumbres
semanticscholar   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Substrate specificity of the Bacillus subtilis BY-kinase PtkA is controlled by alternative activators: TkmA and SalA

open access: yesFrontiers in Microbiology, 2016
Bacterial protein-tyrosine kinases (BY-kinases) are known to regulate different aspects of bacterial physiology, by phosphorylating cellular protein substrates. Physiological cues that trigger BY-kinases activity are largely unexplored. In Proteobacteria,
Abderahmane Derouiche   +3 more
doaj   +1 more source

Protein kinase B [PDF]

open access: yesCurrent Biology, 2000
Vanhaesebroeck B, Alessi, DR: The PI3K-PDK1 connection: more than just a road to PKB.Biochem J 2000, 346:561-576.Scheid MP, Woodgett JR: Protein kinases: six degrees of separation?Curr Biol 2000, 10:R191-R194.Coffer P, Jin J, Woodgett JR: Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.Biochem J 1998 ...
openaire   +2 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy